Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| PTC Therapeutics, Inc.(PTCT) | 921,607 | 918,846 | -2,761 | $62.79M | $74.95M | 10.36% | +$12.16M |
| ACADIA PHARMACEUTICALS INC | 2,872,695 | 2,864,096 | -8,599 | $63.95M | $72.46M | 10.01% | +$8.52M |
| Insmed Incorporated(INSM) | 415,269 | 413,980 | -1,289 | $67.90M | $44.14M | 6.10% | -$23.77M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 325,175 | 348,808 | +23,633 | $30.04M | $40.83M | 5.64% | +$10.80M |
| ANAPTYSBIO INC | 638,161 | 603,489 | -34,672 | $35.39M | $40.74M | 5.63% | +$5.34M |
| BioMarin Pharmaceutical Inc.(BMRN) | 685,182 | 682,777 | -2,405 | $38.71M | $39.07M | 5.40% | +$362.6K |
| Dyne Therapeutics, Inc.(DYN) | 1,652,972 | 1,647,521 | -5,451 | $29.97M | $36.59M | 5.06% | +$6.62M |
| United Therapeutics Corporation(UTHR) | 62,809 | 62,587 | -222 | $37.24M | $33.91M | 4.69% | -$3.33M |
| Disc Medicine, Inc.(IRON) | 401,719 | 416,646 | +14,927 | $25.69M | $30.47M | 4.21% | +$4.79M |
| Biogen Inc.(BIIB) | 140,719 | 140,279 | -440 | $25.80M | $30.31M | 4.19% | +$4.51M |
| Iovance Biotherapeutics, Inc.(IOVA) | 6,349,563 | 5,296,209 | -1,053,354 | $22.29M | $22.03M | 3.04% | -$254.7K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 596,495 | 596,495 | 0 | $12.50M | $19.92M | 2.75% | +$7.42M |
| NovoCure Limited(NVCR) | 1,280,439 | 1,280,439 | 0 | $13.96M | $19.40M | 2.68% | +$5.44M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 864,986 | 864,986 | 0 | $20.21M | $18.91M | 2.61% | -$1.30M |
| ANNEXON INC | 2,948,090 | 2,948,090 | 0 | $16.33M | $16.83M | 2.33% | +$501.2K |
| BICARA THERAPEUTICS INC | 550,408 | 550,408 | 0 | $10.95M | $16.34M | 2.26% | +$5.39M |
| CareDx, Inc.(CDNA) | 531,870 | 531,870 | 0 | $9.23M | $15.16M | 2.09% | +$5.93M |
| Celldex Therapeutics, Inc.(CLDX) | 296,408 | 399,856 | +103,448 | $9.40M | $14.88M | 2.06% | +$5.48M |
| COMPASS THERAPEUTICS INC | 1,514,504 | 5,831,813 | +4,317,309 | $8.01M | $12.77M | 1.76% | +$4.76M |
| Alkermes plc(ALKS) | 242,560 | 242,560 | 0 | $8.58M | $12.71M | 1.76% | +$4.13M |
| FIRST TRACKS BIOTHERAPEUTICS | 0 | 603,489 | +603,489 | $0 | $12.14M | 1.68% | +$12.14M |
| PROTHENA CORP PLC SHS | 1,208,568 | 1,143,155 | -65,413 | $11.75M | $11.19M | 1.55% | -$555.8K |
| Travere Therapeutics, Inc.(TVTX) | 230,453 | 167,525 | -62,928 | $6.85M | $9.52M | 1.32% | +$2.67M |
| Taysha Gene Therapies, Inc.(TSHA) | 1,391,382 | 1,391,382 | 0 | $6.22M | $9.48M | 1.31% | +$3.26M |
| ACLARIS THERAPEUTICS INC | 1,613,430 | 1,613,430 | 0 | $6.05M | $8.54M | 1.18% | +$2.48M |
| Agios Pharmaceuticals, Inc.(AGIO) | 213,601 | 213,601 | 0 | $7.23M | $7.93M | 1.10% | +$700.6K |
| CAPRICOR THERAPEUTICS INC | 229,763 | 229,763 | 0 | $6.98M | $5.53M | 0.76% | -$1.45M |
| ALIGN TECHNOLOGY INC | 41,520 | 31,389 | -10,131 | $7.12M | $5.29M | 0.73% | -$1.82M |
| Oruka Therapeutics, Inc.(ORKA) | 59,985 | 33,546 | -26,439 | $2.94M | $3.19M | 0.44% | +$250.3K |
| Xenon Pharmaceuticals Inc.(XENE) | 51,345 | 51,345 | 0 | $2.99M | $3.10M | 0.43% | +$113.5K |
| Neurocrine Biosciences, Inc.(NBIX) | 18,117 | 18,117 | 0 | $2.39M | $3.05M | 0.42% | +$666.6K |
| EDWARDS LIFESCIENCES CORP | 33,640 | 33,640 | 0 | $2.69M | $3.04M | 0.42% | +$349.2K |
| Stoke Therapeutics, Inc.(STOK) | 84,631 | 84,631 | 0 | $2.76M | $2.77M | 0.38% | +$13.5K |
| Cytokinetics, Incorporated(CYTK) | 32,195 | 32,195 | 0 | $2.12M | $2.74M | 0.38% | +$620.7K |
| PYXIS ONCOLOGY INC | 1,010,510 | 864,277 | -146,233 | $1.48M | $2.60M | 0.36% | +$1.13M |
| EHEALTH INC | 1,482,797 | 1,482,797 | 0 | $1.91M | $2.21M | 0.31% | +$296.6K |
| CRISPR Therapeutics AG(CRSP) | 39,605 | 39,605 | 0 | $1.88M | $2.16M | 0.30% | +$276.0K |
| SAGIMET BIOSCIENCES INC-A | 0 | 250,000 | +250,000 | $0 | $1.93M | 0.27% | +$1.93M |
| Nuvation Bio Inc.(NUVB) | 508,846 | 326,609 | -182,237 | $2.18M | $1.86M | 0.26% | -$327.8K |
| BioNTech SE(BNTX) | 19,614 | 19,614 | 0 | $1.74M | $1.83M | 0.25% | +$81.8K |
| COMPASS Pathways plc(CMPS) | 115,616 | 115,616 | 0 | $639.4K | $1.64M | 0.23% | +$996.6K |
| Humana Inc.(HUM) | 3,985 | 3,985 | 0 | $691.0K | $1.58M | 0.22% | +$892.0K |
| NEWAMSTERDAM PHARMA CO NV ORDINARY SHARES | 0 | 44,359 | +44,359 | $0 | $1.50M | 0.21% | +$1.50M |
| VERASTEM INC | 246,093 | 309,685 | +63,592 | $1.30M | $1.18M | 0.16% | -$121.3K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 1,787 | 1,787 | 0 | $935.4K | $959.5K | 0.13% | +$24.1K |
| UroGen Pharma Ltd.(URGN) | 24,500 | 24,500 | 0 | $440.5K | $901.6K | 0.12% | +$461.1K |
| BICYCLE THERAPEUTICS PLC-ADR | 201,890 | 201,890 | 0 | $936.8K | $856.0K | 0.12% | -$80.8K |
| XERIS BIOPHARMA HOLDINGS INC | 104,410 | 104,410 | 0 | $605.6K | $826.9K | 0.11% | +$221.3K |
| ABEONA THERAPEUTICS INC | 108,865 | 108,865 | 0 | $487.7K | $672.8K | 0.09% | +$185.1K |
| Inspire Medical Systems, Inc.(INSP) | 8,772 | 8,772 | 0 | $452.5K | $391.3K | 0.05% | -$61.1K |
| PROQR THERAPEUTICS NV SHS EURO | 188,807 | 188,807 | 0 | $305.9K | $351.2K | 0.05% | +$45.3K |
| ALDEYRA THERAPEUTICS INC | 155,709 | 155,709 | 0 | $263.1K | $331.7K | 0.05% | +$68.5K |
| AMICUS THERAPEUTICS INC COM | 1,113,045 | 0 | -1,113,045 | $16.09M | $0 | — | -$16.09M |
| Denali Therapeutics Inc.(DNLI) | 234,582 | 0 | -234,582 | $4.50M | $0 | — | -$4.50M |